A research team, led by Giulio Genovese, Ph.D., of the Broad Institute at MIT and Harvard in Boston, focused on precursors for blood cancers like leukaemia, lymphoma and myeloma. Though innovative drug therapies and increasing access to treatments have dramatically improved blood cancer survival, blood cancer remains one of the most common forms of cancer in the United States and worldwide. In 2014, blood cancer accounted for approximately 9.4 percent of the estimated 1, 665, 540 new cancer cases diagnosed across the country. Release date February 2, 2015. |